HR1794: HR1794 Commissioner of Insurance; conduct a comprehensive review of prescription drug pricing and identify strategies to reduce the cost of prescription medications; urge

This resolution does not change any law. Instead, it asks the Commissioner of Insurance, the state official who oversees Georgia's insurance market, to conduct a comprehensive review of prescription drug pricing and to identify strategies that could reduce medication costs for people living in Georgia. The resolution points to rising drug prices, worsened health outcomes when patients skip medication due to cost, and a lack of transparency about the roles of drug manufacturers, pharmacy benefit managers, and insurers. It notes that other states have used tools like all-payer claims data and advisory panels to study drug affordability. The resolution asks that a report of findings and recommendations be sent to the Governor, the Senate President, and the House Speaker, and directs the House Clerk to distribute copies to the Commissioner of Insurance, the public, and the press.

• Urges the Commissioner of Insurance to conduct a comprehensive review of prescription drug pricing in Georgia.
• Asks the Commissioner to identify specific strategies for reducing the cost of prescription medications for Georgia residents.
• Requests that a report of findings and recommendations be submitted to the Governor, the Senate President, and the House Speaker.
• Directs the Clerk of the House to distribute copies of the resolution to the Commissioner of Insurance, the public, and the press.

The Commissioner of Insurance and that office's staff, who would be asked to carry out the review; and indirectly, Georgia patients, families, employers, and public health programs affected by prescription drug costs, along with drug manufacturers, pharmacy benefit managers, and insurers whose pricing roles would be examined.

Because this is a resolution rather than a law, it creates no new requirements or penalties. But if the Commissioner acts on it, the resulting review and report could shape future legislation aimed at making prescription drugs more affordable and transparent for Georgians.

• States a series of findings (the 'whereas' clauses) about rising drug costs, reduced medication adherence, and lack of pricing transparency in the pharmaceutical supply chain.
• Resolves that the House urges the Commissioner of Insurance to review prescription drug pricing and identify cost-reduction strategies.
• Requires a report of findings and recommendations to go to the Governor, the President of the Senate, and the Speaker of the House.
• Directs the Clerk of the House to make copies available to the Commissioner of Insurance, the public, and the press.

1. 2026-03-23House Second Readers (House)
2. 2026-03-20House First Readers (House)
3. 2026-03-19House Hopper (House)

• Bryce Berry (D, HD-056)Primary sponsor
• Tangie Herring (D, HD-145)
• Samuel Park (D, HD-107)
• Spencer Frye (D, HD-122)
• Carolyn Hugley (D, HD-141)
• Eric Gisler (D, HD-121)

• prescription drug prices
• health insurance
• pharmacy costs
• state government reviews